CD4 and multiple sclerosis: In the same line, a recent study of multiple sclerosis pathogenesis identified autoreactive CD4+ T cell clones that can respond to self-peptides as well as peptides from EBV and from the bacteria Akkermansis muciniphila (Wang et al., 2020).